Insignificant disease among men with intermediate-risk prostate cancer

被引：0
|
作者：
Sung Kyu Hong
Emily Vertosick
Daniel D. Sjoberg
Peter T. Scardino
James A. Eastham
机构：
[1] Memorial Sloan-Kettering Cancer Center,Urology Service, Department of Surgery
[2] Seoul National University Bundang Hospital,Department of Urology
[3] Memorial Sloan-Kettering Cancer Center,Department of Epidemiology and Biostatistics
[4] Cornell University,Department of Urology, Weill Cornell Medical College
来源：
World Journal of Urology | 2014年 / 32卷
关键词：
Prostate; Prostatic neoplasms; Insignificant; Intermediate risk; Prediction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1417 / 1421
页数：4
相关论文
共 50 条
  • [1] Insignificant disease among men with intermediate-risk prostate cancer
    Hong, Sung Kyu
    Vertosick, Emily
    Sjoberg, Daniel D.
    Scardino, Peter T.
    Eastham, James A.
    WORLD JOURNAL OF UROLOGY, 2014, 32 (06) : 1417 - 1421
  • [2] Stratification of patients with intermediate-risk prostate cancer
    Jung, Jin-Woo
    Lee, Jung Keun
    Hong, Sung Kyu
    Byun, Seok-Soo
    Lee, Sang Eun
    BJU INTERNATIONAL, 2015, 115 (06) : 907 - 912
  • [3] Outcomes of Active Surveillance for Men With Intermediate-Risk Prostate Cancer
    Cooperberg, Matthew R.
    Cowan, Janet E.
    Hilton, Joan F.
    Reese, Adam C.
    Zaid, Harras B.
    Porten, Sima P.
    Shinohara, Katsuto
    Meng, Maxwell V.
    Greene, Kirsten L.
    Carroll, Peter R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) : 228 - 234
  • [4] The Within-Group Discrimination Ability of the Cancer of the Prostate Risk Assessment Score for Men with Intermediate-Risk Prostate Cancer
    Kang, Ho Won
    Jung, Hae Do
    Lee, Joo Yong
    Kwon, Jong Kyou
    Jeh, Seong Uk
    Cho, Kang Su
    Ham, Won Sik
    Choi, Young Deuk
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (05)
  • [5] Active surveillance for intermediate-risk prostate cancer
    Nayan, Madhur
    Carvalho, Filipe L. F.
    Feldman, Adam S.
    WORLD JOURNAL OF UROLOGY, 2022, 40 (01) : 79 - 86
  • [6] Active surveillance in intermediate-risk prostate cancer
    Klotz, Laurence
    BJU INTERNATIONAL, 2020, 125 (03) : 346 - 354
  • [7] Active surveillance for intermediate-risk prostate cancer
    Madhur Nayan
    Filipe L. F. Carvalho
    Adam S. Feldman
    World Journal of Urology, 2022, 40 : 79 - 86
  • [8] Identifying intermediate-risk candidates for active surveillance of prostate cancer
    Savdie, Richard
    Aning, Jonathan
    So, Alan I.
    Black, Peter C.
    Gleave, Martin E.
    Goldenberg, S. Larry
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 605.e1 - 605.e8
  • [9] Radiation treatment for patients with intermediate-risk prostate cancer
    Greene, David E.
    Mayadev, Jyoti S.
    Valicenti, Richard K.
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (03) : 113 - 124
  • [10] A TCP model for external beam treatment of intermediate-risk prostate cancer
    Walsh, Sean
    van der Putten, Wil
    MEDICAL PHYSICS, 2013, 40 (03)
12345